Prescription video games help children with ADHD to test –

Prescription video games help children with ADHD to test


LONDON (Reuters) – Playing personalized video games can help children with attention deficit hyperactivity disorder (ADHD), according to the results of a pivotal clinical trial announced Monday.

The US company that develops the treatment, Akili is not publicly traded, now plans to apply for regulatory approval with the US Food and Drug Administration. UU In the first half of 2018, paving the way for what would be the first "digital" prescription product.

Akili is an affiliate of PureTech Health, listed on the London list.

Cases of ADHD have increased worldwide in recent decades, and children often receive medications to treat the disorder. Akili's product takes a different approach when using a game to stimulate specific cognitive neural systems in the brain.

In the randomized controlled trial of 348 children and adolescents with ADHD, the AKL-T01 product from Akili showed a statistically significant improvement compared to an active control in attention performance. The control was also a video game.

Medicating ADHD is a big business, with Shire a leading player in the field. Shire is also an investor in Akili.

Reports by Ben Hirschler; Mark Potter edition

Our standards: The principles of trust of Thomson Reuters.
Source link

Leave a Reply

Your email address will not be published.